within Pharmacolibrary.Drugs.ATC.B;

model B01AB01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 4.749999999999999e-06,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 7.000000000000001e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00013000000000000002,
    k12             = 0.036,
    k21             = 0.036
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B01AB01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Heparin is an anticoagulant medication that prevents the formation of blood clots. It is commonly used for the prevention and treatment of venous thromboembolism, pulmonary embolism, and during surgeries where blood clot formation is a risk. It is approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients following intravenous bolus administration.</p><h4>References</h4><ol><li><p>Garcia, DA, et al., &amp; Samama, MM (2012). Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. <i>Chest</i> 141(2 Suppl) e24S–e43S. DOI:<a href=\"https://doi.org/10.1378/chest.11-2291\">10.1378/chest.11-2291</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22315264/\">https://pubmed.ncbi.nlm.nih.gov/22315264</a></p></li><li><p>Holbrook, A, et al., &amp; Guyatt, GH (2012). Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. <i>Chest</i> 141(2 Suppl) e152S–e184S. DOI:<a href=\"https://doi.org/10.1378/chest.11-2295\">10.1378/chest.11-2295</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22315259/\">https://pubmed.ncbi.nlm.nih.gov/22315259</a></p></li><li><p>Kandrotas, RJ (1992). Heparin pharmacokinetics and pharmacodynamics. <i>Clinical pharmacokinetics</i> 22(5) 359–374. DOI:<a href=\"https://doi.org/10.2165/00003088-199222050-00003\">10.2165/00003088-199222050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1505142/\">https://pubmed.ncbi.nlm.nih.gov/1505142</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B01AB01;
